The Summary
Researchers systematically compared 21 senolytic drugs identifying ABT263 and ARV825 as the most potent at eliminating harmful senescent cells. However, some cells survived by maintaining healthy mitochondria. By increasing metabolic workload through a ketogenic diet or SGLT2 inhibitor drugs, researchers stressed these mitochondria. In both lab tests and mouse models, this targeted metabolic stress disabled the cells' survival mechanisms, drastically enhancing the drugs' ability to clear senescent cells and reduce tumor growth.
Why this is interesting
Scientists have struggled to figure out why senolytic drugs fail to kill all targeted zombie cells. This study reveals their secret: stubborn cells survive by efficiently recycling their mitochondria. By applying metabolic stress through a ketogenic diet or SGLT2 inhibitors, we can exhaust their cellular batteries. For readers, this means future therapies might combine specific diets or metabolic medications with cell-clearing drugs, unlocking far more effective ways to eliminate harmful cells and prevent disease.